Naveris

Edit info

Founded: 2017

Location: Natick, MA

Employee range: 11 - 50

Funding: $33.4M A Sep 2022; $19M Dec 2020

Investors: Gurnet Point Capital, TechU Ventures, BrightEdge, the impact and venture capital arm of the American Cancer Society

naveris.com

linkedin.com

job board

Business:

Cancer Diagnostic

About:

Naveris is a privately held, commercial-stage oncology diagnostic company with facilities in both MA and NC. They aim to transform cancer detection through minimally invasive liquid biopsies. Their research revolves around circulating tumor-tissue modified viral DNA (TTMV-DNA) blood tests. This test offers highly sensitive and specific early detection of cancers up to months before symptoms appear. NavDx is a blood test for personalized care of people with HPV-positive head, neck, or anal cancer. Naveris’ blood tests can also assist in monitoring treatment response and disease recurrence, improving patient outcomes. Naveris is investigating the potential of TTMV-DNA for applications in other cancer types beyond HPV-driven cancers.